| Literature DB >> 31604438 |
Wei-Chung Yeh1, Yu-Chung Tsao1,2,3, Wen-Cheng Li1,4, I-Shiang Tzeng5, Liang-Sien Chen1, Jau-Yuan Chen6,7.
Abstract
BACKGROUND: Previous studies have reported that the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio could be a simple clinical indicator of insulin resistance (IR), but the results indicated that there were heterogeneities between different ethnicities. We aimed to investigate the association between TG/HDL-C and IR (as measured by homeostasis model assessment of IR [HOMA-IR]), and establish a clinical prediction rule for IR in middle-aged and elderly Taiwanese.Entities:
Keywords: Anthropometry; Body fat; insulin resistance; Prediction; Triglyceride to high-density lipoprotein cholesterol ratio
Mesh:
Substances:
Year: 2019 PMID: 31604438 PMCID: PMC6790048 DOI: 10.1186/s12944-019-1123-3
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
General characteristics of the study population according to IR positive and IR negative
| Variables | Insulin Resistance | ||||||
|---|---|---|---|---|---|---|---|
| Total | IR positive | IR negative | |||||
| ( | ( | (≧2) | ( | (< 2) | |||
| Age (year) | 64.43 | ±8.45 | 64.59 | ±7.86 | 64.36 | ±8.71 | 0.80 |
| SBP (mmHg) | 129.57 | ±16.72 | 133.97 | ±16.49 | 127.60 | ±16.47 | < 0.001 |
| DBP (mmHg) | 76.94 | ±11.36 | 78.91 | ±10.66 | 76.06 | ±11.57 | 0.02 |
| BMI (kg/m2) | 24.54 | ±3.57 | 26.43 | ±3.69 | 23.70 | ±3.18 | < 0.001 |
| Waist circumference (cm) | 84.99 | ±9.62 | 90.51 | ±9.86 | 82.53 | ±8.43 | < 0.001 |
| ALT (U/L) | 22.66 | ±12.97 | 27.28 | ±17.01 | 20.60 | ±10.06 | < 0.001 |
| Creatinine (mg/dL) | 0.77 | ±0.42 | 0.78 | ±0.33 | 0.77 | ±0.45 | 0.88 |
| eGFR (ml/min/1.73m2) | 113.25 | ±33.21 | 109.95 | ±31.90 | 114.73 | ±33.73 | 0.19 |
| FPG (mg/dL) | 95.54 | ±22.32 | 110.06 | ±31.81 | 89.05 | ±11.59 | < 0.001 |
| HDL-C (mg/dL) | 54.51 | ±13.91 | 48.68 | ±11.37 | 57.12 | ±14.17 | < 0.001 |
| HOMA-IR index | 1.86 | ±1.39 | 3.39 | ±1.58 | 1.18 | ±0.44 | < 0.001 |
| LDL-C (mg/dL) | 118.47 | ±32.16 | 112.11 | ±29.83 | 121.31 | ±32.80 | 0.01 |
| Total Cholesterol (mg/dL) | 197.19 | ±35.69 | 191.46 | ±34.08 | 119.75 | ±36.16 | 0.03 |
| TG/HDL | 2.52 | ±1.83 | 3.48 | ±2.32 | 2.09 | ±1.37 | < 0.001 |
| Triglyceride (mg/dL) | 121.20 | ±62.93 | 153.46 | ±76.04 | 106.77 | ±49.88 | < 0.001 |
| Uric Acid (mg/dL) | 5.74 | ±1.41 | 6.10 | ±1.36 | 5.58 | ±1.41 | 0.001 |
| WBC (1000/uL) | 6.04 | ±1.59 | 6.71 | ±1.79 | 5.74 | ±1.39 | < 0.001 |
| Men, n(%) | 139 | (34.9) | 41 | (33.3) | 98 | (35.6) | 0.66 |
| Current smoking, n(%) | 42 | (10.6) | 12 | (9.8) | 30 | (10.9) | 0.73 |
| Alcohol drinking ≧2 times/week, n(%) | 75 | (18.8) | 17 | (13.8) | 58 | (21.1) | 0.09 |
| Regular exercise, n(%) | 326 | (81.9) | 92 | (74.8) | 234 | (85.1) | 0.01 |
| Vegetarian, n(%) | 22 | (5.5) | 5 | (4.1) | 17 | (6.2) | 0.39 |
| ACR ≧30 mg/g, n(%) | 74 | (18.6) | 31 | (25.2) | 43 | (15.6) | 0.02 |
| HTN, n(%) | 199 | (50.0) | 84 | (68.3) | 115 | (41.8) | < 0.001 |
| DM, n(%) | 77 | (19.3) | 48 | (39.0) | 29 | (10.5) | < 0.001 |
| Hyperlipidemia, n(%) | 259 | (65.1) | 93 | (75.6) | 166 | (60.4) | 0.003 |
| Metabolic syndrome | 141 | (35.4) | 89 | (72.4) | 52 | (18.9) | < 0.001 |
Notes: Clinical characteristics are expressed as mean ± SD for continuous variables and n (%) for categorical variables. P-value were derived from independent two-sample t-test for continuous variables and chi-square test for categorical variables
Abbreviations: SBP systolic blood pressure; DBP diastolic blood pressure; BMI body mass index; eGFR estimated glomerular filtration rate; FPG fasting plasma glucose; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol; WBC white blood cell count; ACR albumin to creatinine ratio; HTN hypertension; DM diabetes mellitus
The correlation between HOMA-IR index and cardiovascular disease risk factors
| Variables | HOMA-IR index ( | |||
|---|---|---|---|---|
| Unadjusted | Adjusted for age | |||
| Pearson’s coefficient | Pearson’s coefficient | |||
| Age (year) | 0.02 | 0.70 | NA | NA |
| SBP (mmHg) | 0.17 | 0.001 | 0.17 | 0.001 |
| DBP (mmHg) | 0.09 | 0.079 | 0.10 | 0.06 |
| BMI (kg/m2) | 0.43 | < 0.001 | 0.433 | < 0.001 |
| Waist circumference (cm) | 0.41 | < 0.001 | 0.41 | < 0.001 |
| FPG (mg/dL) | 0.50 | < 0.001 | 0.50 | < 0.001 |
| HDL-C (mg/dL) | −0.31 | < 0.001 | −0.31 | < 0.001 |
| LDL-C (mg/dL) | −0.10 | 0.06 | −0.09 | 0.06 |
| TG (mg/dL) | 0.33 | < 0.001 | 0.33 | < 0.001 |
| TG/HDL | 0.35 | < 0.001 | 0.35 | < 0.001 |
Abbreviations: SBP systolic blood pressure; DBP diastolic blood pressure; BMI body mass index; FPG fasting plasma glucose; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol; TG triglyceride
Fig. 1Representation of the correlation analysis: there was a trend toward a positive correlation between HOMA-IR-index and TG/HDL
Association between TG/HDL levels and HOMA-IR index
| Variables | Odds ratio | 95% C.I. | |
|---|---|---|---|
| Model 1 | |||
| Sex (men versus women) | 0.67 | 0.41–1.10 | 0.11 |
| TG/HDL | 1.59 | 1.38–1.83 | < 0.001 |
| Model 2 | |||
| Sex (men versus women) | 0.59 | 0.34–1.00 | 0.05 |
| Age (year) | 1.01 | 0.98–1.04 | 0.52 |
| BMI (kg/m2) | 1.24 | 1.15–1.34 | < 0.001 |
| TG/HDL | 1.48 | 1.28–1.72 | < 0.001 |
| Model 3 | |||
| Sex (men versus women) | 0.59 | 0.34–1.04 | 0.07 |
| Age (year) | 0.99 | 0.96–1.02 | 0.58 |
| BMI (kg/m2) | 1.23 | 1.13–1.33 | < 0.001 |
| HTN (yes versus no) | 1.88 | 1.11–3.18 | 0.02 |
| DM (yes versus no) | 5.41 | 2.93–10.01 | < 0.001 |
| Hyperlipidemia (yes versus no) | 0.95 | 0.53–1.70 | 0.85 |
| TG/HDL | 1.45 | 1.23–1.72 | < 0.001 |
| Model 4 | |||
| Sex (men versus women) | 0.64 | 0.36–1.15 | 0.14 |
| Age (year) | 0.99 | 0.96–1.02 | 0.51 |
| BMI (kg/m2) | 1.23 | 1.13–1.33 | < 0.001 |
| Smoking (yes versus no) | 0.68 | 0.26–1.77 | 0.42 |
| HTN (yes versus no) | 1.90 | 1.12–3.21 | 0.02 |
| DM (yes versus no) | 5.44 | 2.93–10.08 | < 0.001 |
| Hyperlipidemia (yes versus no) | 0.97 | 0.54–1.74 | 0.91 |
| TG/HDL | 1.45 | 1.23–1.72 | < 0.001 |
Abbreviations: BMI body mass index; HDL-C high-density lipoprotein cholesterol; TG triglyceride; HTN hypertension; DM diabetes mellitus; CI confidence interval
Fig. 2ROC curve for TG/HDL as a predictor of HOMA-IR index
The areas under ROC curve (AUC), sensitivity, specificity by the optimized cut-off points for TG/HDL in predicting HOMA-IR index
| Variables | AUC | Cut-off | Sensitivity | Specificity | |
|---|---|---|---|---|---|
| TG/HDL | 0.729 | < 0.001 | 2.197 | 0.724 | 0.651 |
Abbreviations: HDL-C high-density lipoprotein cholesterol; TG triglyceride; ROC curve receiver operating characteristic curve; CI confidence interval